<code id='FC00A72604'></code><style id='FC00A72604'></style>
    • <acronym id='FC00A72604'></acronym>
      <center id='FC00A72604'><center id='FC00A72604'><tfoot id='FC00A72604'></tfoot></center><abbr id='FC00A72604'><dir id='FC00A72604'><tfoot id='FC00A72604'></tfoot><noframes id='FC00A72604'>

    • <optgroup id='FC00A72604'><strike id='FC00A72604'><sup id='FC00A72604'></sup></strike><code id='FC00A72604'></code></optgroup>
        1. <b id='FC00A72604'><label id='FC00A72604'><select id='FC00A72604'><dt id='FC00A72604'><span id='FC00A72604'></span></dt></select></label></b><u id='FC00A72604'></u>
          <i id='FC00A72604'><strike id='FC00A72604'><tt id='FC00A72604'><pre id='FC00A72604'></pre></tt></strike></i>

          Home / hotspot / fashion

          fashion


          fashion

          author:hotspot    Page View:484
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In